Member Exclusive

Researchers suggest RIOK 1 as a new target for cancer therapeutics

A group led by Tilman Brummer (University of Freiburg, Breisgau, Germany) has collaborated with an international team of researchers to identify a new target for cancer therapy; RIOK1.

Go to the profile of Rachel Coleby
May 11, 2017

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.